Lexeo Therapeutics to Participate in the Chardan Healthcare Conference
Globe Newswire•08/10/2026•07:00 ET
0
Key Highlights
- ➤Lexeo to participate in Chardan’s 10th Annual Healthcare Conference on October 20, 2026
- ➤Fireside chat scheduled for 9:30am ET and webcast live on Lexeo’s website
- ➤Lexeo advances LX2006 for Friedreich ataxia and LX2020 for PKP2 arrhythmogenic cardiomyopathy
NEW YORK, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO) a clinical stage company focused on reshaping the path of genetic diseases with high unmet need, today announced that the Company will participate in a fireside chat at Chardan’s 10th Annual Healthcare Conference on October 20, 2026 at 9:30am ET.
The event will be webcast live under the Events & Presentations tab in the Investors section of the Company’s website. A replay of the webcast will be available on the Lexeo website following the presentation.
Get started
Create a free account to read the full story.